IBM, KPMG, Merck and Walmart to collaborate as part of FDA’s program to evaluate the use of blockchain to protect pharmaceutical product integrity
Dateline City:
ARMONK, N.Y., NEW YORK, N.Y., KENILWORTH, N.J., and BENTONVILLE, Ark.
The FDA pilot program explores innovative and emerging approaches for the tracing and verification of prescription products
ARMONK, N.Y., NEW YORK, N.Y., KENILWORTH, N.J., and BENTONVILLE, Ark., June 13, 2019 IBM (NYSE:IBM), KPMG, Merck (NYSE:MRK), and Walmart (NYSE: WMT) today announced that the companies have been selected by the United States Food and Drug Administration (FDA) to be included in a program in support of the U.S. Drug Supply Chain Security Act (DSCSA) that addresses requirements to identify, track and trace prescription medicines and vaccines distributed within the United States.
Language:
English
